Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-02

AUTHORS

J M Soler, J G Previnaire, P Denys, E Chartier-Kastler

ABSTRACT

STUDY DESIGN: Open, before-after study. OBJECTIVE: To assess the efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction (ED) in spinal cord-injured (SCI) patients. SETTING: Home- and clinic-based assessments in the outpatient department at the Centre Bouffard Vercelli, Cerbère France. METHODS: Clinic trials with Sildenafil (Viagra) on 120 patients, Tadalafil (Cialis) on 54 patients and Vardenafil (Levitra) on 66 patients were performed. Flexible doses of PDE5 inhibitors were given depending on efficacy and tolerability, from 50 to 100 mg for Sildenafil, and from 10 to 20 mg for Vardenafil and Tadalafil. Each trial was performed after a week's interval. The efficacy was self-assessed by the patients on a six-point quantitative scale assessment. The response to treatment was assessed at home in 90 patients (57 patients on Sildenafil, 12 patients on Vardenafil and 21 patients on Tadalafil) using the International Index of Erectile Function (IIEF). RESULTS: In clinic trials, PDE5 inhibitors were effective (rigidity enough for penetration) in 85% of the patients on Sildenafil, 74% of the patients on Vardenafil and 72% of the patients on Tadalafil. The mean duration of erection was 34, 28 and 26 min, respectively. Adverse effects were mild, usually attenuated with continued dosing. More than 70% of the patients on Vardenafil and Tadalafil required higher doses of 20 mg, whereas 50 mg of Sildenafil was effective in 55% of the patients. Two-thirds of our patients on Tadalafil reported a duration of action longer than 24 h. The presence of an upper motor neuron lesion was significantly associated with therapeutic success, lower motor neuron lesions and cauda equina patients were poor responders. Other variables such as completeness of lesion had no impact. In the follow-up visits, the IIEF global scores and three IIEF domains (erectile function, intercourse satisfaction and overall satisfaction) were significantly improved in all patients. Patients on Sildenafil showed a significant improvement of orgasmic function, ejaculation (Question 9) and orgasm (Question 10). CONCLUSION: Sildenafil, Vardenafil and Tadalafil are all effective and well-tolerated treatments for ED in SCI patients. Although no statistical analysis could be applied on these data, these results might indicate that Sildenafil is more effective in treating ED. Clinic trials are important for proper dose titration and appropriate education of the patients. More... »

PAGES

3101950

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.sc.3101950

DOI

http://dx.doi.org/10.1038/sj.sc.3101950

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050482698

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16801935


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carbolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erectile Dysfunction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphodiesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Purines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reaction Time", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sildenafil Citrate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spinal Cord Injuries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tadalafil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vardenafil Dihydrochloride", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Centre Bouffard Vercelli, Laboratoire d'urodynamique et de sexologie, Cerb\u00e8re, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soler", 
        "givenName": "J M", 
        "id": "sg:person.0752542567.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752542567.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fondation Hopale", 
          "id": "https://www.grid.ac/institutes/grid.418271.9", 
          "name": [
            "Centre Calv\u00e9, Fondation Hopale, Berck sur mer, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Previnaire", 
        "givenName": "J G", 
        "id": "sg:person.01020655767.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020655767.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Raymond Poincar\u00e9 University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414291.b", 
          "name": [
            "Service de Reeducation Neurologique, Hopital Raymond Poincare, Garches, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Denys", 
        "givenName": "P", 
        "id": "sg:person.01055303126.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055303126.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Raymond Poincar\u00e9 University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414291.b", 
          "name": [
            "Service de Reeducation Neurologique, Hopital Raymond Poincare, Garches, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chartier-Kastler", 
        "givenName": "E", 
        "id": "sg:person.013046243044.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013046243044.88"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0090-4295(97)00238-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002373146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1531-8249(199907)46:1<15::aid-ana5>3.0.co;2-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006899343"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0090-4295(02)01690-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011260868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0090-4295(02)01690-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011260868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101198", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013513318", 
          "https://doi.org/10.1038/sj.sc.3101198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101198", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013513318", 
          "https://doi.org/10.1038/sj.sc.3101198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3100803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021273842", 
          "https://doi.org/10.1038/sj.sc.3100803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3100803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021273842", 
          "https://doi.org/10.1038/sj.sc.3100803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021301649", 
          "https://doi.org/10.1038/sj.sc.3101210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021301649", 
          "https://doi.org/10.1038/sj.sc.3101210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101846", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021579964", 
          "https://doi.org/10.1038/sj.sc.3101846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101846", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021579964", 
          "https://doi.org/10.1038/sj.sc.3101846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101846", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021579964", 
          "https://doi.org/10.1038/sj.sc.3101846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00326825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027163843", 
          "https://doi.org/10.1007/bf00326825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000020278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027834400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2005.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029534358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031358108", 
          "https://doi.org/10.1038/sj.sc.3101617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031358108", 
          "https://doi.org/10.1038/sj.sc.3101617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sc.1990.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033249150", 
          "https://doi.org/10.1038/sc.1990.38"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sc.1990.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033249150", 
          "https://doi.org/10.1038/sc.1990.38"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035230504", 
          "https://doi.org/10.1038/sj.sc.3101011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.sc.3101011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035230504", 
          "https://doi.org/10.1038/sj.sc.3101011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2004.12.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035609796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sc.1972.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048528713", 
          "https://doi.org/10.1038/sc.1972.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sc.1972.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048528713", 
          "https://doi.org/10.1038/sc.1972.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2008-1041163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057536531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10790268.2003.11753687", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058371884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(17)40889-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079453943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080457631", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081885455", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-02", 
    "datePublishedReg": "2007-02-01", 
    "description": "STUDY DESIGN: Open, before-after study.\nOBJECTIVE: To assess the efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction (ED) in spinal cord-injured (SCI) patients.\nSETTING: Home- and clinic-based assessments in the outpatient department at the Centre Bouffard Vercelli, Cerb\u00e8re France.\nMETHODS: Clinic trials with Sildenafil (Viagra) on 120 patients, Tadalafil (Cialis) on 54 patients and Vardenafil (Levitra) on 66 patients were performed. Flexible doses of PDE5 inhibitors were given depending on efficacy and tolerability, from 50 to 100 mg for Sildenafil, and from 10 to 20 mg for Vardenafil and Tadalafil. Each trial was performed after a week's interval. The efficacy was self-assessed by the patients on a six-point quantitative scale assessment. The response to treatment was assessed at home in 90 patients (57 patients on Sildenafil, 12 patients on Vardenafil and 21 patients on Tadalafil) using the International Index of Erectile Function (IIEF).\nRESULTS: In clinic trials, PDE5 inhibitors were effective (rigidity enough for penetration) in 85% of the patients on Sildenafil, 74% of the patients on Vardenafil and 72% of the patients on Tadalafil. The mean duration of erection was 34, 28 and 26 min, respectively. Adverse effects were mild, usually attenuated with continued dosing. More than 70% of the patients on Vardenafil and Tadalafil required higher doses of 20 mg, whereas 50 mg of Sildenafil was effective in 55% of the patients. Two-thirds of our patients on Tadalafil reported a duration of action longer than 24 h. The presence of an upper motor neuron lesion was significantly associated with therapeutic success, lower motor neuron lesions and cauda equina patients were poor responders. Other variables such as completeness of lesion had no impact. In the follow-up visits, the IIEF global scores and three IIEF domains (erectile function, intercourse satisfaction and overall satisfaction) were significantly improved in all patients. Patients on Sildenafil showed a significant improvement of orgasmic function, ejaculation (Question 9) and orgasm (Question 10).\nCONCLUSION: Sildenafil, Vardenafil and Tadalafil are all effective and well-tolerated treatments for ED in SCI patients. Although no statistical analysis could be applied on these data, these results might indicate that Sildenafil is more effective in treating ED. Clinic trials are important for proper dose titration and appropriate education of the patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.sc.3101950", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1077060", 
        "issn": [
          "1362-4393", 
          "1476-5624"
        ], 
        "name": "Spinal Cord", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "name": "Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men", 
    "pagination": "3101950", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f07ba9f41376272de7db056c7a65a10fc90d98a99a0a960867779261c3098d83"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16801935"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9609749"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.sc.3101950"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050482698"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.sc.3101950", 
      "https://app.dimensions.ai/details/publication/pub.1050482698"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29186_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/3101950"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.sc.3101950'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.sc.3101950'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.sc.3101950'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.sc.3101950'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      69 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.sc.3101950 schema:about N001d98aaa7d34c3386d6c35cfcb36dd2
2 N160c3b86da3f45e3b75f8cddc3e3ddc8
3 N1b324a34d7fe4f899216455ecbdf1515
4 N328f3c4d81f24f868f5068cd35f7805e
5 N3aab576d318d4790a49c659ea57cd4e2
6 N45fc6a569e254e188a74d993971373d0
7 N46d6dc52a09045f99a29acbb3dbdef27
8 N4a38bc9e0069430f8ae9e7b9bf924412
9 N583061bdeb46441a854cf2bf41da0ab7
10 N610616e6b52c4f5a8559636d1ad397b9
11 N72084bb423ec42ea9fda70e58f397d59
12 N7352fc38cb00465091c903a7875b433f
13 N75a033ef639f4a9b881bceb05c8ff248
14 N797013ad59cd45c08fe97511479c302f
15 N999a286ce981430bb598f449ce9abd68
16 Naee2d36c051a42699ead1e08b59063aa
17 Ndae29bfaad0b4cfda6b01faf49083c2f
18 Ndafee69cac0d4cc6983909bd6ce3c713
19 Ndfacf91b922745ecab9733cfec4ac819
20 Ne2b23fc37a054fcba388dde81342a1ff
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author Na87e78ea878a44cbb4f0b4b83ff2f457
24 schema:citation sg:pub.10.1007/bf00326825
25 sg:pub.10.1038/sc.1972.34
26 sg:pub.10.1038/sc.1990.38
27 sg:pub.10.1038/sj.sc.3100803
28 sg:pub.10.1038/sj.sc.3101011
29 sg:pub.10.1038/sj.sc.3101198
30 sg:pub.10.1038/sj.sc.3101210
31 sg:pub.10.1038/sj.sc.3101617
32 sg:pub.10.1038/sj.sc.3101846
33 https://app.dimensions.ai/details/publication/pub.1080457631
34 https://app.dimensions.ai/details/publication/pub.1081885455
35 https://doi.org/10.1002/1531-8249(199907)46:1<15::aid-ana5>3.0.co;2-u
36 https://doi.org/10.1016/j.eururo.2004.12.005
37 https://doi.org/10.1016/j.eururo.2005.02.019
38 https://doi.org/10.1016/s0022-5347(17)40889-5
39 https://doi.org/10.1016/s0090-4295(02)01690-4
40 https://doi.org/10.1016/s0090-4295(97)00238-0
41 https://doi.org/10.1055/s-2008-1041163
42 https://doi.org/10.1080/10790268.2003.11753687
43 https://doi.org/10.1159/000020278
44 schema:datePublished 2007-02
45 schema:datePublishedReg 2007-02-01
46 schema:description STUDY DESIGN: Open, before-after study. OBJECTIVE: To assess the efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction (ED) in spinal cord-injured (SCI) patients. SETTING: Home- and clinic-based assessments in the outpatient department at the Centre Bouffard Vercelli, Cerbère France. METHODS: Clinic trials with Sildenafil (Viagra) on 120 patients, Tadalafil (Cialis) on 54 patients and Vardenafil (Levitra) on 66 patients were performed. Flexible doses of PDE5 inhibitors were given depending on efficacy and tolerability, from 50 to 100 mg for Sildenafil, and from 10 to 20 mg for Vardenafil and Tadalafil. Each trial was performed after a week's interval. The efficacy was self-assessed by the patients on a six-point quantitative scale assessment. The response to treatment was assessed at home in 90 patients (57 patients on Sildenafil, 12 patients on Vardenafil and 21 patients on Tadalafil) using the International Index of Erectile Function (IIEF). RESULTS: In clinic trials, PDE5 inhibitors were effective (rigidity enough for penetration) in 85% of the patients on Sildenafil, 74% of the patients on Vardenafil and 72% of the patients on Tadalafil. The mean duration of erection was 34, 28 and 26 min, respectively. Adverse effects were mild, usually attenuated with continued dosing. More than 70% of the patients on Vardenafil and Tadalafil required higher doses of 20 mg, whereas 50 mg of Sildenafil was effective in 55% of the patients. Two-thirds of our patients on Tadalafil reported a duration of action longer than 24 h. The presence of an upper motor neuron lesion was significantly associated with therapeutic success, lower motor neuron lesions and cauda equina patients were poor responders. Other variables such as completeness of lesion had no impact. In the follow-up visits, the IIEF global scores and three IIEF domains (erectile function, intercourse satisfaction and overall satisfaction) were significantly improved in all patients. Patients on Sildenafil showed a significant improvement of orgasmic function, ejaculation (Question 9) and orgasm (Question 10). CONCLUSION: Sildenafil, Vardenafil and Tadalafil are all effective and well-tolerated treatments for ED in SCI patients. Although no statistical analysis could be applied on these data, these results might indicate that Sildenafil is more effective in treating ED. Clinic trials are important for proper dose titration and appropriate education of the patients.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N383e7fdf6ebd44ceb8704aeb36e27336
51 Nb6dfd33d92ef41d4b3d0e404bd216ad4
52 sg:journal.1077060
53 schema:name Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men
54 schema:pagination 3101950
55 schema:productId N2f8e25665df148938c6fdd22f3ccfa7e
56 N40eb25e3d9b34bc4aeafe7df4098c9f9
57 N67b9ce0116494ab28a9b608213e7e194
58 N815987bf72e044ab99faaee596f5b569
59 N9ea3c98ab77e4825af11781daaa564c2
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050482698
61 https://doi.org/10.1038/sj.sc.3101950
62 schema:sdDatePublished 2019-04-11T11:52
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N027aa7fcc68f4b48b63283a8e6c133e8
65 schema:url http://www.nature.com/articles/3101950
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N001d98aaa7d34c3386d6c35cfcb36dd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Sildenafil Citrate
71 rdf:type schema:DefinedTerm
72 N027aa7fcc68f4b48b63283a8e6c133e8 schema:name Springer Nature - SN SciGraph project
73 rdf:type schema:Organization
74 N096ef8c17bef4a40877186f1b019fdcf rdf:first sg:person.01055303126.30
75 rdf:rest Nfce4204a333643a89e1b05d549174438
76 N160c3b86da3f45e3b75f8cddc3e3ddc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Adult
78 rdf:type schema:DefinedTerm
79 N195bc01bf32c46889e5fe1c865573ef9 schema:name Centre Bouffard Vercelli, Laboratoire d'urodynamique et de sexologie, Cerbère, France
80 rdf:type schema:Organization
81 N1b324a34d7fe4f899216455ecbdf1515 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Piperazines
83 rdf:type schema:DefinedTerm
84 N2f8e25665df148938c6fdd22f3ccfa7e schema:name dimensions_id
85 schema:value pub.1050482698
86 rdf:type schema:PropertyValue
87 N328f3c4d81f24f868f5068cd35f7805e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Male
89 rdf:type schema:DefinedTerm
90 N383e7fdf6ebd44ceb8704aeb36e27336 schema:issueNumber 2
91 rdf:type schema:PublicationIssue
92 N3aab576d318d4790a49c659ea57cd4e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Middle Aged
94 rdf:type schema:DefinedTerm
95 N40eb25e3d9b34bc4aeafe7df4098c9f9 schema:name pubmed_id
96 schema:value 16801935
97 rdf:type schema:PropertyValue
98 N45fc6a569e254e188a74d993971373d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Erectile Dysfunction
100 rdf:type schema:DefinedTerm
101 N46d6dc52a09045f99a29acbb3dbdef27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Spinal Cord Injuries
103 rdf:type schema:DefinedTerm
104 N4a38bc9e0069430f8ae9e7b9bf924412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Phosphodiesterase Inhibitors
106 rdf:type schema:DefinedTerm
107 N583061bdeb46441a854cf2bf41da0ab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Vardenafil Dihydrochloride
109 rdf:type schema:DefinedTerm
110 N610616e6b52c4f5a8559636d1ad397b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Analysis of Variance
112 rdf:type schema:DefinedTerm
113 N67b9ce0116494ab28a9b608213e7e194 schema:name doi
114 schema:value 10.1038/sj.sc.3101950
115 rdf:type schema:PropertyValue
116 N72084bb423ec42ea9fda70e58f397d59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 N7352fc38cb00465091c903a7875b433f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Retrospective Studies
121 rdf:type schema:DefinedTerm
122 N75a033ef639f4a9b881bceb05c8ff248 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Triazines
124 rdf:type schema:DefinedTerm
125 N797013ad59cd45c08fe97511479c302f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Sulfones
127 rdf:type schema:DefinedTerm
128 N815987bf72e044ab99faaee596f5b569 schema:name nlm_unique_id
129 schema:value 9609749
130 rdf:type schema:PropertyValue
131 N999a286ce981430bb598f449ce9abd68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Reaction Time
133 rdf:type schema:DefinedTerm
134 N9ea3c98ab77e4825af11781daaa564c2 schema:name readcube_id
135 schema:value f07ba9f41376272de7db056c7a65a10fc90d98a99a0a960867779261c3098d83
136 rdf:type schema:PropertyValue
137 N9ee5ba1f7c724d1eb32a5d3df38ccb9d rdf:first sg:person.01020655767.96
138 rdf:rest N096ef8c17bef4a40877186f1b019fdcf
139 Na87e78ea878a44cbb4f0b4b83ff2f457 rdf:first sg:person.0752542567.51
140 rdf:rest N9ee5ba1f7c724d1eb32a5d3df38ccb9d
141 Naee2d36c051a42699ead1e08b59063aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Purines
143 rdf:type schema:DefinedTerm
144 Nb6dfd33d92ef41d4b3d0e404bd216ad4 schema:volumeNumber 45
145 rdf:type schema:PublicationVolume
146 Ndae29bfaad0b4cfda6b01faf49083c2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Surveys and Questionnaires
148 rdf:type schema:DefinedTerm
149 Ndafee69cac0d4cc6983909bd6ce3c713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Tadalafil
151 rdf:type schema:DefinedTerm
152 Ndfacf91b922745ecab9733cfec4ac819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Carbolines
154 rdf:type schema:DefinedTerm
155 Ne2b23fc37a054fcba388dde81342a1ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Imidazoles
157 rdf:type schema:DefinedTerm
158 Nfce4204a333643a89e1b05d549174438 rdf:first sg:person.013046243044.88
159 rdf:rest rdf:nil
160 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
161 schema:name Medical and Health Sciences
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
164 schema:name Clinical Sciences
165 rdf:type schema:DefinedTerm
166 sg:journal.1077060 schema:issn 1362-4393
167 1476-5624
168 schema:name Spinal Cord
169 rdf:type schema:Periodical
170 sg:person.01020655767.96 schema:affiliation https://www.grid.ac/institutes/grid.418271.9
171 schema:familyName Previnaire
172 schema:givenName J G
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020655767.96
174 rdf:type schema:Person
175 sg:person.01055303126.30 schema:affiliation https://www.grid.ac/institutes/grid.414291.b
176 schema:familyName Denys
177 schema:givenName P
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055303126.30
179 rdf:type schema:Person
180 sg:person.013046243044.88 schema:affiliation https://www.grid.ac/institutes/grid.414291.b
181 schema:familyName Chartier-Kastler
182 schema:givenName E
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013046243044.88
184 rdf:type schema:Person
185 sg:person.0752542567.51 schema:affiliation N195bc01bf32c46889e5fe1c865573ef9
186 schema:familyName Soler
187 schema:givenName J M
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752542567.51
189 rdf:type schema:Person
190 sg:pub.10.1007/bf00326825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027163843
191 https://doi.org/10.1007/bf00326825
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/sc.1972.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048528713
194 https://doi.org/10.1038/sc.1972.34
195 rdf:type schema:CreativeWork
196 sg:pub.10.1038/sc.1990.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033249150
197 https://doi.org/10.1038/sc.1990.38
198 rdf:type schema:CreativeWork
199 sg:pub.10.1038/sj.sc.3100803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021273842
200 https://doi.org/10.1038/sj.sc.3100803
201 rdf:type schema:CreativeWork
202 sg:pub.10.1038/sj.sc.3101011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035230504
203 https://doi.org/10.1038/sj.sc.3101011
204 rdf:type schema:CreativeWork
205 sg:pub.10.1038/sj.sc.3101198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013513318
206 https://doi.org/10.1038/sj.sc.3101198
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/sj.sc.3101210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021301649
209 https://doi.org/10.1038/sj.sc.3101210
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/sj.sc.3101617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031358108
212 https://doi.org/10.1038/sj.sc.3101617
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/sj.sc.3101846 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021579964
215 https://doi.org/10.1038/sj.sc.3101846
216 rdf:type schema:CreativeWork
217 https://app.dimensions.ai/details/publication/pub.1080457631 schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1081885455 schema:CreativeWork
219 https://doi.org/10.1002/1531-8249(199907)46:1<15::aid-ana5>3.0.co;2-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1006899343
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.eururo.2004.12.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035609796
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.eururo.2005.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029534358
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s0022-5347(17)40889-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079453943
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0090-4295(02)01690-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011260868
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s0090-4295(97)00238-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002373146
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1055/s-2008-1041163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057536531
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1080/10790268.2003.11753687 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058371884
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1159/000020278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027834400
236 rdf:type schema:CreativeWork
237 https://www.grid.ac/institutes/grid.414291.b schema:alternateName Raymond Poincaré University Hospital
238 schema:name Service de Reeducation Neurologique, Hopital Raymond Poincare, Garches, France
239 rdf:type schema:Organization
240 https://www.grid.ac/institutes/grid.418271.9 schema:alternateName Fondation Hopale
241 schema:name Centre Calvé, Fondation Hopale, Berck sur mer, France
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...